Kilitch Drugs (India) Limited (BOM:524500)
India
· Delayed Price · Currency is INR 320.10
+1.50 (0.47%)
At close: Mar 9, 2026
Kilitch Drugs (India) Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 267.01 | 146.01 | 104.48 | 73.67 | 36.71 | Upgrade
|
| Depreciation & Amortization | - | 21.59 | 23.38 | 26.96 | 16.13 | 11.41 | Upgrade
|
| Other Amortization | - | 1.08 | 1.69 | 0.13 | 0.1 | 0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 8.43 | 8.43 | 8.43 | 8.43 | 8.43 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -65.22 | -13.89 | -9.88 | -13.59 | -12.03 | Upgrade
|
| Loss (Gain) on Equity Investments | - | 0 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Stock-Based Compensation | - | - | - | - | - | -1.57 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 11.6 | 31.39 | 31.39 | 10.86 | 15.33 | Upgrade
|
| Other Operating Activities | - | 27.19 | 30.74 | 13.18 | 14.11 | 10.75 | Upgrade
|
| Change in Accounts Receivable | - | -220.75 | -119.17 | -154.88 | -202.97 | -86.65 | Upgrade
|
| Change in Inventory | - | -113.22 | -19.43 | 29.56 | -14.14 | 19.71 | Upgrade
|
| Change in Accounts Payable | - | 285.69 | -122.86 | -19.95 | 227.15 | 465.61 | Upgrade
|
| Change in Other Net Operating Assets | - | -47.98 | 18.34 | -3.57 | -61.94 | -11.15 | Upgrade
|
| Operating Cash Flow | - | 175.42 | -15.35 | 25.86 | 57.83 | 456.59 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | -55.29% | -87.33% | 923.51% | Upgrade
|
| Capital Expenditures | - | -468.73 | -64.5 | -38.12 | -82.02 | -362.98 | Upgrade
|
| Investment in Securities | - | 52.66 | -15.72 | 94.34 | -72.98 | -2.72 | Upgrade
|
| Other Investing Activities | - | 16.61 | -1.34 | 22.93 | 2.49 | -9.99 | Upgrade
|
| Investing Cash Flow | - | -399.47 | -81.56 | 79.15 | -152.5 | -375.69 | Upgrade
|
| Short-Term Debt Issued | - | 177.78 | 94.53 | 17.62 | 56.28 | 21.95 | Upgrade
|
| Total Debt Issued | - | 177.78 | 94.53 | 17.62 | 56.28 | 21.95 | Upgrade
|
| Net Debt Issued (Repaid) | - | 177.78 | 94.53 | 17.62 | 56.28 | 21.95 | Upgrade
|
| Issuance of Common Stock | - | - | 38.58 | - | 0.88 | 0.6 | Upgrade
|
| Other Financing Activities | - | -45.34 | -45.04 | -24.78 | 13.12 | -6.41 | Upgrade
|
| Financing Cash Flow | - | 132.43 | 88.07 | -7.16 | 70.28 | 16.14 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | 0 | - | - | - | Upgrade
|
| Net Cash Flow | - | -91.61 | -8.84 | 97.85 | -24.39 | 97.04 | Upgrade
|
| Free Cash Flow | - | -293.31 | -79.85 | -12.26 | -24.19 | 93.61 | Upgrade
|
| Free Cash Flow Margin | - | -14.79% | -5.17% | -0.88% | -2.12% | 13.66% | Upgrade
|
| Free Cash Flow Per Share | - | -18.24 | -5.01 | -0.79 | -1.55 | 6.05 | Upgrade
|
| Cash Interest Paid | - | 50.41 | 59.29 | 49.19 | 11.98 | - | Upgrade
|
| Cash Income Tax Paid | - | 84.7 | 70.36 | 43.31 | 25.36 | 10.13 | Upgrade
|
| Levered Free Cash Flow | - | -370.5 | -175.19 | -74.79 | -364.59 | 100.46 | Upgrade
|
| Unlevered Free Cash Flow | - | -339 | -138.13 | -44.04 | -357.1 | 105.17 | Upgrade
|
| Change in Working Capital | - | -96.26 | -243.12 | -148.84 | -51.9 | 387.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.